Results 21 to 30 of about 174,855 (309)

HIV Associated Sensory Neuropathy [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: In the era of highly active antiretroviral therapy (HAART), sensory neuropathies have increased in prevalence. We have documented the frequency and profile of the two most common forms of sensory neuropathies associated with Human ...
Amruth G, Praveen-Kumar S, Nataraju B, Nagaraja BS   +3 more
doaj   +1 more source

Hypertriglyceridemia in Antiretroviral Therapy [PDF]

Journal of the International AIDS Society, 2005
Elevated serum triglycerides, total cholesterol, very low-density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol have been reported in the literature from areas where experience with antiretroviral drugs has amassed. Up until recently the use of antiretroviral drugs in Nigeria on a wide scale was a rarity owing largely to
Imarhiagbe, Frank, Kubeyinje, Emmanuel
openaire   +3 more sources

Initiation of antiretroviral therapy

Indian Journal of Sexually Transmitted Diseases and AIDS, 2014
With the widespread availability of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Further, the current antiretroviral drug combinations are safer and the availability of newer monitoring assays and guidelines has vastly improved the patient management.
Pandhi, Deepika, Ailawadi, Pallavi
openaire   +3 more sources

Antiretroviral therapy in Africa [PDF]

BMJ, 2004
We should stop and think about the risks of resistance, and ways of minimising them, before increasing access to antiretroviral therapy in Africa Demands for the introduction of antiretroviral therapy into Africa have been growing over the past few years.
Warren, Stevens, Steve, Kaye, Tumani, Corrah   +2 more
openaire   +2 more sources

Antiretroviral Therapy in the Clinic [PDF]

Journal of Virology, 2010
ABSTRACT Antiretroviral therapy in the developed world has resulted in substantial reductions in HIV-associated morbidity and mortality, changing an HIV diagnosis from a likely death sentence into a manageable chronic infection (F. J. Palella, Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D.
Athe M N, Tsibris, Martin S, Hirsch
openaire   +2 more sources

Variable impact on mortality of AIDS‐Defining events diagnosed during combination antiretroviral therapy: Not All AIDS‐defining conditions are created equal

, 2009
Background The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)–defining events (ADEs) has not been assessed among patients initiating combination antiretroviral therapy.
Justice, Amy, Saaq, M., Crevel, R. van, Sterne, Jonathan A C, Justice A., Reiss, Peter, HARRIS R, R. Harris, Staszewski, S., Mocroft, A., Sabin, Caroline, G. Fatkenheuer, D'Arminio-Monforte, A., Fatkenheuer, G., Egger, M., Phillips, E., Groot, R. de, Harris, Ross, Gill J., KITAHATA M, S. Grabar, Sterne, J.A., F. Bonnet, May, M., Post, F., CASABONA J, A. Justice, Ven, A.J.A.M. van der, Mocroft, A, Casabona J., H. Furrer, J. Casabona, M. Egger, Reiss P., Antiretroviral Therapy Cohort Collaboration, Casabona, Jordi, D'ARMINIO MONFORTE A, FATKENHEUER G, STERNE JA, De Wit, Stéphane, Kitahata, Mari, Furrer H., d'Arminio Monforte, Antonella, Bonnet, F., C. Sabin, Sterne, Jonathan A. C., MONTRONI, MARIA, MAY M, SAAG M., Furrer, H., A. Mocroft, Staszewski, Schlomo, Justice, Amy C, Justice, A., MINOLI, LORENZO, Reiss, P., Sabin C., MANCUSO, Salvatrice, Antiretroviral Therapy Cohort Collaboration Mocroft A., Saag, Michael, Saag, M., J. Gill, Keuter, M., Warris, A., Hogg R., Staszewxski S., Sterne J.A., Clumeck, Nathan, S. Staszewski, Casabona, J., P. Reiss, Bonnef, VULLO, Vincenzo, Kitahata, M., Mocroft, Amanda, Furrer, Hansjakob, Koopmans †, P.P., Gill, J., Gill, John, Bonnet, Fabrice, GRABAR S, REISS P, ?, ?, Hogg, Robert, M. Kitahata, CIARDI, Maria Rosa, et al., EGGER M, Niesters, Bert, Egger, Matthias, Harris R., Fatkenheuer G., May, Margaret T, JUSTICE A, HOGG R, May M., Grabar, Sophie, Fatkenheuer, Gerd, ANTIRETROVIRAL THERAPY COHORT COLLABORATION ART CC, May, Margaret, Egger M., d'Arminio Monforte A., M. May, GILL J, Grabar S., D'Arminio Monforte, A., Grabar, S., A. d'Arminio Monforte, Kitahata M., SABIN C, R. Hogg, Harris, R., Sabin, C., Post, Frank, J. A. Sterne, STASZEWSKI S, FURRER H, Gyssens, I.C.J., MOCROFT A, M. Saag, Hogg, R., BONNET F   +121 more
core   +1 more source

Benchmarks for antiretroviral therapy [PDF]

Journal of Clinical Investigation, 2000
Sharp declines in HIV-related morbidity and mortality over the last 4 years are due in part to a fuller understanding of the pathogenesis of HIV infection, the availability of sensitive assays that measure viral replication in vivo, and the use of combinations of antiretroviral drugs that profoundly suppress viral replication for prolonged periods (i.e.
O J, Cohen, A S, Fauci
openaire   +2 more sources

Factors of Loss to Follow-up Antiretroviral Therapy in Islanded Area

Unnes Journal of Public Health, 2018
Loss to follow-up of antiretroviral therapy is when PLWHA (People Living with HIV/AIDS) do not come for antiretroviral therapy for more than 3 months. This study aimed to determine the factors of loss to follow-up antiretroviral therapy for PLWHA at Prof.
Thomas Laga Boro, Rafael Paun, Marthen R Pellokila   +2 more
doaj   +1 more source

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration [PDF]

, 2005
Background The genetic differences among HIV-1 subtypes may be critical to clinical management and drug resistance surveillance as antiretroviral treatment is expanded to regions of the world where diverse non-subtype-B viruses predominate.Methods and ...
Wynhoven, B, Cane, P, Holguin, A, Pedro Cahn, Maria Belen Bouzas, Africa Holguin, Luis F Brigido, Sirivichayakul, S, Anne-Mieke Vandamme, Camacho, R, Efron, B, Koya Ariyoshi, Grossman, Z, Robert W Shafer, Shafer, RW, Bouzas, MB, Brian Wynhoven, Ricardo Camacho, Jonathan N Weber, Harrigan, PR, Ariyoshi, K, Ana Patricia Carvalho, Rosangela Rodrigues, Rudich, H, Candice Pillay, Soares, MA, Katzenstein, DA, Vandamme, AM, Clarke, J, Lynn Morris, Snoeck, J, Soriano, V, Rodrigues, R, Brigido, LF, Wataru Sugiura, Praphan Phanuphak, Kantor, R, Sugiura, W, John Clarke, Jonathan M Schapiro, Rami Kantor, David A Katzenstein, Carvalho, AP, P Richard Harrigan, Patricia Cane, Phanuphak, P, Brad Efron, Pillay, D, Pillay, C, Sunee Sirivichayakul, Joke Snoeck, Cahn, P, Hagit Rudich, Schapiro, JM, Morris, L, Zehava Grossman, Amilcar Tanuri, Tanuri, A, Weber, JN, Vincent Soriano, Deenan Pillay, Marcelo A Soares   +61 more
core   +1 more source

Survival rate of HIV-infected children after initiation of the antiretroviral therapy and its predictors in Ethiopia: A facility-based retrospective cohort

SAGE Open Medicine, 2019
Objective: To determine the survival rate and predictors of HIV-infected children on antiretroviral therapy at two selected facilities in North Ethiopia.
Getachew Arage, Mekonnen Assefa, Teshager Worku, Agumasie Semahegn   +3 more
doaj   +1 more source